1. Home
  2. PSTV vs AMBO Comparison

PSTV vs AMBO Comparison

Compare PSTV & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
    SELLHOLDBUYas of 5 hours ago
  • AMBO
    SELLHOLDBUYas of 5 hours ago
  • Stock Information
  • Founded
  • PSTV 1996
  • AMBO 2000
  • Country
  • PSTV United States
  • AMBO United States
  • Employees
  • PSTV N/A
  • AMBO N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • AMBO Other Consumer Services
  • Sector
  • PSTV Health Care
  • AMBO Real Estate
  • Exchange
  • PSTV Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • PSTV 6.3M
  • AMBO 6.0M
  • IPO Year
  • PSTV N/A
  • AMBO 2010
  • Fundamental
  • Price
  • PSTV $1.17
  • AMBO $2.09
  • Analyst Decision
  • PSTV Strong Buy
  • AMBO
  • Analyst Count
  • PSTV 2
  • AMBO 0
  • Target Price
  • PSTV $13.50
  • AMBO N/A
  • AVG Volume (30 Days)
  • PSTV 60.3K
  • AMBO 423.9K
  • Earning Date
  • PSTV 03-04-2025
  • AMBO 12-30-2024
  • Dividend Yield
  • PSTV N/A
  • AMBO N/A
  • EPS Growth
  • PSTV N/A
  • AMBO N/A
  • EPS
  • PSTV N/A
  • AMBO N/A
  • Revenue
  • PSTV $5,725,000.00
  • AMBO $7,839,000.00
  • Revenue This Year
  • PSTV $32.12
  • AMBO N/A
  • Revenue Next Year
  • PSTV N/A
  • AMBO N/A
  • P/E Ratio
  • PSTV N/A
  • AMBO N/A
  • Revenue Growth
  • PSTV 52.63
  • AMBO N/A
  • 52 Week Low
  • PSTV $0.93
  • AMBO $1.00
  • 52 Week High
  • PSTV $2.67
  • AMBO $6.30
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 52.88
  • AMBO 50.75
  • Support Level
  • PSTV $1.04
  • AMBO $2.08
  • Resistance Level
  • PSTV $1.35
  • AMBO $3.45
  • Average True Range (ATR)
  • PSTV 0.09
  • AMBO 0.67
  • MACD
  • PSTV 0.01
  • AMBO -0.03
  • Stochastic Oscillator
  • PSTV 68.42
  • AMBO 20.21

Stock Price Comparison Chart: PSTV vs AMBO

PSTV
AMBO
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045505560PSTV VS AMBO

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use